[{"AccountsPayableCurrent_0_Q1_USD":3265000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2573000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":52000.0,"LongTermInvestments_0_Q1_USD":6530000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":34000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1202000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2573000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":0.0,"ShortTermInvestments_0_Q1_USD":87496000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":94026000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":29500000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":85863000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_1_Q1_USD":0.0,"PreferredStockLiquidationPreferenceValue_0_Q1_USD":0.0,"InvestmentIncomeInterest_1_Q1_USD":749000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":73000.0,"OperatingLeaseExpense_1_Q1_USD":200000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-21463000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":247350000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":6530000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":87496000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":70659000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":72035000.0,"PaymentsForTenantImprovements_1_Q1_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1_Q1_USD":-153000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-4000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-149000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.08,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2280000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3103000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":511000.0,"OperatingLeaseLiability_0_Q1_USD":3614000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":784000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":567000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":865000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":890000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":918000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":928000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":4398000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":-4000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":60065000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":44659000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":17340000.0,"OtherAssetsNoncurrent_0_Q1_USD":160000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":7108653.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":33761000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":44659000.0,"LiabilitiesCurrent_0_Q1_USD":13548000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":172803000.0,"Liabilities_0_Q1_USD":16685000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":158000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":4000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-21306000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-18351000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4692000.0,"CommonStockValue_0_Q1_USD":3000.0,"CommonStockSharesOutstanding_0_Q1_shares":25033736.0,"CommonStockSharesIssued_0_Q1_shares":25389987.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":72035000.0,"AssetsCurrent_0_Q1_USD":162436000.0,"Assets_0_Q1_USD":172803000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4793113.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-24000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.86,"NetIncomeLoss_1_Q1_USD":-21310000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":98000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2905000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":812000.0,"ShareBasedCompensation_1_Q1_USD":2573000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingIncomeLoss_1_Q1_USD":-22032000.0,"OperatingExpenses_1_Q1_USD":22032000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":0.0,"AccruedLiabilitiesCurrent_0_Q1_USD":9772000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":24704651.0,"StockholdersEquity_0_Q1_USD":156118000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-91211000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1397000.0,"ProfitLoss_1_Q1_USD":-21310000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":44659000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-23000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"Ticker":"MIRM","CIK":"1759425","name":"MIRUM PHARMACEUTICALS, INC.","OfficialName":"Mirum Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"824673616.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]